Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion.

Abstract

PURPOSE:

To assess the efficacy of intravitreal Pegaptanib sodium (Macugen(®)) injection in the management of refractory macular edema secondary to branch retinal vein occlusion.

METHODS:

This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib sodium.

RESULTS:

After three months follow-up, both visual acuity and macular edema, measured by optical coherence tomography and fluorescence angiography, dramatically improved.

CONCLUSION:

Pegaptanib sodium is a safe and efficacy treatment for macular edema secondary to branch retinal vein occlusion.

• Authors: Patricia Udaondo, Salvador Garcia-Delpech, David Salom, Maria Garcia-Pous, Manuel Diaz-Llopis
• Journal: Clinical ophthalmology (Auckland, N.Z.) (Clin Ophthalmol) Vol. 5 Pg. 941-4 ( 2011) ISSN: 1177-5483 [Electronic] New Zealand
• PMID: 21792283 (Publication Type: Case Reports)